1933 Industries Inc (TGIFF) Fair Value & Analysis
Healthcare · US · Market cap $2.8M
1933 Industries Inc
TGIFF · US
Fair value as of: Jun 26, 2026
From 13 valuation models · updated 7 days ago
Fair value updated Jun 26, 2026 — revised from $0.0100 to $0.0047 (−52.5%) since Jun 25, 2026. Share price +9.8% over the past month.
Price vs Fair Value (12 months)
12‑month range $0.0036 – $0.0140 · the $0.0045 price screens below the $0.0047 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
1933 Industries Inc (TGIFF) currently trades at $0.0045, while our model-based Fair Value estimate is $0.0047 — implying the stock looks roughly 5.5% undervalued today. We read business quality at 41/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, 1933 Industries Inc generated revenue of $17.0M at a net margin of 2.8%. Revenue declined 10.6% year over year. Net debt stands at $2.9M. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
1933 Industries Inc., together with its subsidiaries, engages in the cultivation, extraction, and production of cannabis products in the United States. It operates through AMA and Infused MFG segments. The company offers craft-style cannabis, branded flower, infused pre-rolls, full spectrum oils, distillates, and blends of terpenes; vaporizer products and boutique concentrate, such as shatter, crumble, batter, sugar wax, diamonds, and cured and live resins under the AMA and Level X brands. It also provides cannabidiol, and cannabinol infused products. The company sells its products through licensed dispensaries, as well as direct to consumers via e-commerce at cannahemp.com. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. 1933 Industries Inc. is headquartered in Vancouver, Canada.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
1933 Industries Inc reported revenue of $17.4M in FY2025 versus $12.0M in FY2021, a compound +9.9%/yr. Reported net income was −$217K in FY2025.
Is TGIFF fairly valued? → Check now
Similar stocks
6 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 1276 | HK$57.85 | HK$29.84 | -48% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,863 | ₹1,039 | -44% |
| Zoetis Inc Z1TS34 | R$24.45 | R$6.33 | -74% |
| Hansoh Pharmaceutical Group 3692 | HK$29.58 | HK$18.75 | -37% |
| Divi's Laboratories Limited DIVISLAB | ₹6,788 | ₹2,035 | -70% |
| Swedish Orphan Biovitrum AB SOBI | kr 444.80 | kr 440.64 | -1% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is 1933 Industries Inc (TGIFF) undervalued?
What is the fair value of TGIFF?
What is the quality score of TGIFF?
What is the revenue of 1933 Industries Inc (TGIFF)?
What is the net profit margin of TGIFF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.